Trial Profile
A multicentre phase III randomised controlled study of Theratope vaccine for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2015
Price :
$35
*
At a glance
- Drugs Cancer vaccine Theratope (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 17 Jan 2011 Status changed from active, no longer recruiting to completed as reportted by ISRCTN: Current Controlled Trials.
- 28 Nov 2005 New trial record.